Stockholm, Sweden 13 January 2025
Arex Advisor is happy to welcome Emily Staaf, Senior Market Access Consultant, to the team. Emily brings a comprehensive skill set honed through her work on strategic and operational market access projects in both the pharmaceutical and MedTech sectors. Her proficiency spans the Nordic region as well as global markets, equipping her with a robust understanding of pricing and reimbursement systems, real world evidence, medical writing, and economic modelling. With her experience of early scientific advice for European projects, Emily will be a valuable resource for clients facing the Joint Scientific Consultation (JSC), part of the EU Health Technology Assessment Regulation (EU-HTAR).
“Market Access, where science meets business, is a crucial factor for success in the life science industry. With the recently implemented EU-HTAR, the joint perspective of market access and regulatory affairs is more relevant than ever. Emily’s recruitment perfectly aligns with our mission to help medicinal products reach the market, and we are excited to have her on board.” Linda Thunell, CEO
Prior to joining Arex Advisor, Emily held a position as Senior Specialist in Health Economics and Outcomes Research (HEOR) at Cencora PharmaLex. Emily will be based in Gothenburg, Sweden.
About us: Arex Advisor offers strategic advice and operational support in pharmaceutical research and business development for Pharma, BioTech, and MedTech. Our mission is to help leaders and companies realise projects and reach goals. We are passionate about the successful processes, from development to commercialisation, of important medicines – ultimately contributing to improving the lives of patients.
Contact:
Linda Thunell
